In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Compass Therapeutics Inc (NASDAQ: CMPX) closed at $1.89 in the last session, up 3.85% from day before closing price of $1.82. In other words, the price has increased by $3.85 from its previous closing price. On the day, 0.73 million shares were traded. CMPX stock price reached its highest trading level at $1.94 during the session, while it also had its lowest trading level at $1.84.
Ratios:
We take a closer look at CMPX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 14.96 and its Current Ratio is at 14.96. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
On February 24, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $12.
On February 19, 2025, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $12.Piper Sandler initiated its Overweight rating on February 19, 2025, with a $12 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 09 ’25 when GORDON CARL L sold 3,571,428 shares for $1.59 per share. The transaction valued at 5,678,571 led to the insider holds 0 shares of the business.
ORBIMED ADVISORS LLC sold 3,571,428 shares of CMPX for $5,678,571 on Apr 09 ’25. The Director now owns 0 shares after completing the transaction at $1.59 per share. On Apr 09 ’25, another insider, OrbiMed Genesis Master Fund, L, who serves as the Director of the company, bought 3,571,428 shares for $1.59 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CMPX now has a Market Capitalization of 261352976 and an Enterprise Value of 141265920. For the stock, the TTM Price-to-Sale (P/S) ratio is 307.47 while its Price-to-Book (P/B) ratio in mrq is 2.08. Its current Enterprise Value per Revenue stands at 166.195 whereas that against EBITDA is -2.521.
Stock Price History:
The Beta on a monthly basis for CMPX is 1.19, which has changed by 0.11176467 over the last 52 weeks, in comparison to a change of 0.09765589 over the same period for the S&P500. Over the past 52 weeks, CMPX has reached a high of $4.08, while it has fallen to a 52-week low of $0.76. The 50-Day Moving Average of the stock is -13.36%, while the 200-Day Moving Average is calculated to be 0.37%.
Shares Statistics:
According to the various share statistics, CMPX traded on average about 1.48M shares per day over the past 3-months and 718010 shares per day over the past 10 days. A total of 137.82M shares are outstanding, with a floating share count of 87.84M. Insiders hold about 36.48% of the company’s shares, while institutions hold 39.35% stake in the company. Shares short for CMPX as of 1744675200 were 8169591 with a Short Ratio of 5.51, compared to 1741910400 on 4607296. Therefore, it implies a Short% of Shares Outstanding of 8169591 and a Short% of Float of 11.1999996.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
